In
Insud Pharma
Buenos Aires ARFounded 19915,000 employees
Private CappharmaPrivateOncologyInfectious Disease
Platform: LatAm Generics
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| INS-127 | INS-127 | Phase 2/3 | 2 | CD3 | CSUPancreatic Ca | ||
| Zenoinavolisib | INS-9170 | Preclinical | 1 | PI3Kα | PsA | ||
| INS-860 | INS-860 | Phase 2 | 2 | EZH2 | Urothelial CaWilms | ||
| Datofotisoran | INS-521 | Phase 1/2 | 2 | PARP | MCC |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)